Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Aspartic Acid Proteases as Therapeutic Targets

John Wiley and Sons Ltd, Aug 2010, Pages: 640


  Description  
   Table of Contents   
   Author   
    
    
     
  Enquire before Buying   
  Send to a Friend   

In this ground-breaking practical reference, the family of aspartic acid proteases is described from a drug developer's perspective. The first part provides a general introduction to the family of aspartic acid proteases, their physiological functions, molecular structure and inhibition. Parts two to five present various case studies of successful protease inhibitor drug design and development, as well as current and potential uses of such inhibitors in pharmaceutical medicine, covering the major therapeutic targets HIV-1 protease, renin, beta-secretase, gamma-secretase,plasmepsins and fungal proteases.

A ready reference aimed primarily at professionals in the pharmaceutical industry, as well as for anyone studying proteases and their function.



Customers who bought this item also bought

Competitor Analysis: Tau and Amyloid Beta Targeted Therapy of Alzheimer’s Disease

Nitric Oxide - Therapeutics, Markets and Companies

HIV-1 Integrase: Mechanism and Inhibitor Design

Molecular Diagnostics - Technologies, Markets and Companies

Alzheimers and Parkinsons Disease - Global Strategic Business Report

Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011

Computational Chemistry Part 3

Development of Therapeutic Agents Handbook

The Medical Management of HIV/AIDS

Drugs for Neglected Diseases Part 2



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds